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Abstract
Benzyl isothiocyanate (BITC), a constituent of edible cruciferous vegetables, inhibits growth of breast cancer cells but the
mechanisms underlying growth inhibitory effect of BITC are not fully understood. Here, we demonstrate that BITC treatment
causes FoxO1-mediated autophagic death in cultured human breast cancer cells. The BITC-treated breast cancer cells (MDA-
MB-231, MCF-7, MDA-MB-468, BT-474, and BRI-JM04) and MDA-MB-231 xenografts from BITC-treated mice exhibited several
features characteristic of autophagy, including appearance of double-membrane vacuoles (transmission electron
microscopy) and acidic vesicular organelles (acridine orange staining), cleavage of microtubule-associated protein 1 light
chain 3 (LC3), and/or suppression of p62 (p62/SQSTM1 or sequestosome 1) expression. On the other hand, a normal human
mammary epithelial cell line (MCF-10A) was resistant to BITC-induced autophagy. BITC-mediated inhibition of MDA-MB-231
and MCF-7 cell viability was partially but statistically significantly attenuated in the presence of autophagy inhibitors 3-
methyl adenine and bafilomycin A1. Stable overexpression of Mn-superoxide dismutase, which was fully protective against
apoptosis, conferred only partial protection against BITC-induced autophagy. BITC treatment decreased phosphorylation of
mTOR and its downstream targets (P70s6k and 4E-BP1) in cultured MDA-MB-231 and MCF-7 cells and MDA-MB-231
xenografts, but activation of mTOR by transient overexpression of its positive regulator Rheb failed to confer protection
against BITC-induced autophagy. Autophagy induction by BITC was associated with increased expression and acetylation of
FoxO1. Furthermore, autophagy induction and cell growth inhibition resulting from BITC exposure were significantly
attenuated by small interfering RNA knockdown of FoxO1. In conclusion, the present study provides novel insights into the
molecular circuitry of BITC-induced cell death involving FoxO1-mediated autophagy.
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Introduction
Breast cancer continues to be a leading cause of cancer-related
deaths in women worldwide even after remarkable progress
towards targeted therapies [1]. Novel approaches for chemopre-
vention of breast cancer are clinically attractive because many of
the known risk factors associated with this devastating disease (e.g.,
family history and delayed menopause) are beyond human control
and currently available chemopreventive options, such as selective
estrogen receptor modulators (e.g., tamoxifen) and aromatase
inhibitors, are sub-optimal [2–5]. Previous research in our
laboratory as well as by others identifies benzyl isothiocyanate
(BITC), a constituent of edible cruciferous vegetables such as
garden cress, as a promising chemopreventive agent against breast
cancer [6–11]. Possible clinical application of BITC for prevention
of mammary cancer is supported by the following preclinical
observations: (a) BITC inhibits chemically-induced mammary
cancer in Sprague-Dawley rats [6], (b) BITC inhibits growth of
cultured human breast cancer cells regardless of the estrogen
receptor expression or the p53 status [7–9], (c) growth of a triple
negative human breast cancer cell line (MDA-MB-231) subcuta-
neously implanted in female athymic mice is significantly retarded
by BITC administration [10], and (d) dietary feeding of 3 mmol
BITC/g diet suppresses mammary hyperplasia and carcinoma
incidence and/or burden in MMTV-neu transgenic mice without
any signs of overt toxicity [11]. Furthermore, population-based
case-control studies suggest that dietary intake of cruciferous
vegetables may be protective against breast cancer [12,13].
Even though the mechanisms underlying growth inhibitory
effect of BITC against breast cancer are not fully understood, we
have shown previously that BITC treatment inhibits complex III
of the mitochondrial respiratory chain leading to production of
reactive oxygen species (ROS), activation of c-Jun N-terminal
kinase-Bax axis, and ultimately apoptotic cell death in MDA-MB-
231 and MCF-7 cells [9,14]. Molecular circuitry of BITC-induced
apoptosis downstream of ROS production also involves suppres-
sion of X-linked inhibitor of apoptosis protein [15]. We showed
further that while p53 tumor suppressor is dispensable for BITC-
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induced apoptosis, this chemopreventive agent is capable of
suppressing oncogenic actions of leptin through inhibition of signal
transducer and activator of transcription 3 in human breast cancer
cells [15,16].
Because ROS production is implicated in induction of
autophagy [17], which is an evolutionary conserved process for
bulk degradation of cellular components including organelles (e.g.,
mitochondria) and considered a valid cancer chemotherapeutic
target [18], we raised the question of whether growth suppressive
effect of BITC was associated with autophagy induction. The
present study systematically addresses this question using cultured
breast cancer cells (MDA-MB-231, MCF-7, MDA-MB-468, BT-
474, and BRI-JM04), a spontaneously immortalized and non-
tumorigenic normal human mammary epithelial cell line (MCF-
10A), and MDA-MB-231 xenografts from control and BITC-
treated mice as models.
Results
BITC Treatment Caused Autophagy in Cultured and
Xenografted Human Breast Cancer Cells
Fig. 1A depicts representative transmission electron microscopic
images of MDA-MB-231 cells following 12 h treatment with
dimethyl sulfoxide (DMSO; control) or BITC (2.5 mM). DMSO-
treated control MDA-MB-231cells mostly exhibited healthy
looking mitochondria. On the other hand, exposure of MDA-
MB-231 cells to 2.5 mM BITC for 6 h (results not shown) or 12 h
(Fig. 1A) resulted in appearance of double-membrane vacuoles
resembling autophagosomes (identified by red arrows in Fig. 1A),
which were infrequent in DMSO-treated control cells. Autophagic
response to BITC treatment was confirmed by analysis of acidic
vesicular organelles (AVOs) and cleavage of microtubule-associ-
ated protein 1 light chain 3 (LC3), which are hallmarks of
autophagy [19–21]. The AVOs were visualized by fluorescence
microscopy following staining with the lysosomotropic agent
acridine orange. Acridine orange is a weak base that is able to
move freely across biological membranes characterized by weak
and diffuse green fluorescence. The protonated form of acridine
orange accumulates in acidic compartments (lysosomes) and forms
aggregates, which is characterized by yellow-orange fluorescence.
Treatment of cells with BITC for 6 h (MDA-MB-231) or 9 h
(MCF-7) resulted in formation of yellow-orange AVOs, which
were rare in DMSO-treated control cells (Fig. 1B). Cleavage of
LC3, a protein critical for autophagic machinery [19], is another
widely used criterion for detection of autophagy. During
autophagy LC3 (18 kDa) is cleaved to a 16 kDa intermediate
(referred to as LC3-II) that localizes to the autophagosomes
[20,21]. Cleavage and recruitment of LC3-II to autophagosomes is
characterized by punctate staining [21]. Staining for LC3 was
diffuse in DMSO-treated control MDA-MB-231 and MCF-7 cells
(Fig. 1C). The MDA-MB-231 and MCF-7 cells treated with BITC
displayed punctate pattern of LC3 staining (Fig. 1C). To confirm
the autophagic response to BITC, a panel of breast cell lines
including MDA-MB-468 (ER negative, mutant p53), and BT-474
(ER positive, mutant p53), BRI-JM04 (ER negative), and a normal
human mammary epithelial cell line (MCF-10A) were used. As
seen in Fig. 1B, AVOs were also observed in MDA-MB-468, BT-
474, and BRI-JM04 cells exposed to 5 mM BITC for 6 h.
However, BITC-induced AVOs were not evident in MCF-10A
normal human breast cell line. In addition, BITC exposure
displayed punctate pattern of LC3-II staining in MDA-MB-468,
BT-474, and BRI-JM04 breast cancer cells, but not in the MCF-
10A cell line (Fig. 1C). Consistent with these results, cleavage of
LC3 on treatment with BITC was also clearly visible in all five
breast cancer cell lines (MDA-MB-231, MCF-7, MDA-MB-468,
BT-474, and BRI-JM04), but not in the normal MCF-10A cells
(Fig. 2A).
We have demonstrated previously that BITC treatment
significantly retards growth of MDA-MB-231 xenografts in female
athymic mice without causing any side effects [10]. We used
archived tumor tissues from the same experiment to determine
whether BITC treatment caused cleavage of LC3 in vivo. As shown
in Fig. 2B, expression of full-length as well as cleaved LC3 was
barely detectable in the MDA-MB-231 xenografts from control
mice. On the other hand, the MDA-MB-231 tumors from the
BITC-treated mice exhibited induction as well as cleavage of LC3
(Fig. 2B). Quantitatively, protein level of cleaved LC3 (LC3-II) was
increased by about 26-fold in tumors from 7.5 mmol BITC-treated
mice in comparison with those from control mice (P,0.05 by one-
way ANOVA with Dunnett’s adjustment; Fig. 2C).
Additional evidence for in vivo autophagy was obtained by
immunohistochemical analysis of p62 (also known as p62/
SQSTM1 or sequestosome 1). The p62 protein not only interacts
with LC3 but also accumulates in mouse models of defective
autophagy [22,23]. Immunohistochemical staining for p62 is
shown in Fig. 3A (left panel). As seen in Fig. 3A (right panel), p62
expression was quantitatively decreased by about 54% in the
MDA-MB-231 tumors from BITC-treated mice compared with
those from control mice (P=0.043 by two-tailed Student’s t-test).
Collectively, these results provided evidence for BITC-induced
autophagy in cultured and xenografted human breast cancer cells.
Pharmacologic Suppression of Autophagy Attenuated
Growth Inhibitory Effect of BITC
Next, we designed experiments to determine the functional
significance of autophagy in BITC-mediated suppression of cell
viability using a pair of chemical inhibitors of autophagy, 3-methyl
adenine (3-MA) and bafilomycin A1 (Baf). For these experiments,
the cells were first pre-treated for 2 h with 5 mM 3-MA or 3 nM
Baf and then exposed to 2.5 mM BITC for 6 h in the presence of
the inhibitor prior to trypan blue dye exclusion assay. The
inhibitor concentrations were optimized based on lack of cellular
toxicity and inhibition of BITC-mediated cleavage of LC3 (results
not shown). Viability of MDA-MB-231, MCF-7, and MDA-MB-
468 cells was decreased by about 38–48% upon 6 h treatment
with 2.5 mM BITC (aP,0.05 compared with DMSO-treated
control by one-way ANOVA with Tukey’s or Bonferroni’s
adjustment; Fig. 3B). While 3-MA alone (an inhibitor of
phosphatidylinositol 3-phosphate kinase) was non-toxic to these
cells, suppression of cell viability resulting from BITC exposure
was partially but statistically significantly attenuated in the
presence of 3-MA (bP,0.05 between BITC alone group and
BITC+3-MA group, Fig. 3B). Similarly a non-toxic concentration
of Baf (an inhibitor of vacuolar type H+-ATPase) conferred partial
yet significant protection against BITC-mediated growth inhibi-
tion in both MDA-MB-231 and MCF-7 cells (Fig. 3B). Because
BITC treatment also causes apoptotic cell death in these breast
cancer cells [9,14], partial protection against cell killing is
expected. Thus, it is reasonable to conclude that autophagy
induction by BITC did not impart a survival advantage in breast
cancer cells.
BITC-Induced Autophagy Was Partially Attenuated by
Superoxide Dismutase Overexpression
We have shown previously that the BITC-induced apoptotic cell
death in human breast cancer cells is accompanied by ROS
production [14]. Moreover, the BITC-induced ROS production
BITC Causes FoxO1-Mediated Autophagy
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and apoptosis are significantly reversed by overexpression of
catalase or superoxide dismutase (SOD) [14]. We raised the
question of whether BITC-induced autophagy in our model was
dependent on ROS production, which was likely based on recent
literature implicating ROS in autophagy induction [17]. The
MDA-MB-231 cells with stable overexpression of manganese
SOD (Mn-SOD) were partially resistant to BITC-mediated (6 h
treatment) cleavage of LC3 compared with empty vector-
transfected control cells (Fig. 3C). The LC3 punctate staining
resulting from BITC exposure was also partially attenuated by
Mn-SOD overexpression (results not shown). Mn-SOD overex-
pressing MDA-MB-231 cells were relatively more resistant to
killing by BITC exposure compared with empty vector-transfected
control (31% decrease in cell viability in empty vector-transfected
cells in comparison with DMSO-treated control versus 21%
decrease in cell viability in Mn-SOD overexpressing cells in
Figure 1. BITC treatment causes autophagy in breast cancer cells. (A) Representative transmission electron micrographs depicting
ultrastructure of MDA-MB-231 cells following 12 h treatment with DMSO (control) or 2.5 mM BITC. Scale bar- 2 mm (10,0006direct magnification).
Boxed area is amplified in right panel for control and BITC-treated cells for better visualization. Structures resembling autophagosomes in BITC-
treated MDA-MB-231 cells are identified with red arrows. (B) Visualization of acidic vesicular organelles (yellow-orange) following acridine orange
staining in DMSO-treated control and BITC-treated cells (6 h treatment except for MCF-7 cells that were treated for 9 h; objective magnification-
1006). (C) Fluorescence microscopy for LC3 localization in cells treated with DMSO or 5 mM BITC for 6 h (9 h for MCF-7 cells; objective magnification-
1006). Except for transmission electron microscopy, each experiment was repeated at least twice with similar results.
doi:10.1371/journal.pone.0032597.g001
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comparison with respective DMSO-treated control), but the
difference did not reach statistical significance (Fig. 3D). On the
other hand, BITC-mediated increase in histone-associated DNA
fragment release into the cytosol (a measure of apoptotic cell
death) was completely abolished in the Mn-SOD overexpressing
cells in comparison with empty vector transfected cells (results not
shown). These results indicated that the ROS production alone did
not fully account for the BITC-induced autophagy in MDA-MB-
231 cells. Nevertheless, it was obvious that BITC treatment
simultaneously triggered both apoptotic and autophagic cell death
in breast cancer cells.
BITC Treatment Caused Suppression of mTOR Activity
Serine-threonine kinase mTOR has emerged as a key negative
regulator of autophagy in cancer cells [20]. Initially we determined
the effect of BITC treatment on phosphorylation of mTOR as well
as its downstream substrates P70s6k and 4E-BP1. As shown in
Fig. 4A, BITC-treated MDA-MB-231 and MCF-7 cells exhibited
a marked decrease in levels of phospho-(S2448)-mTOR, phospho-
(S65)-4E-BP1, and phospho-(T389)-P70s6k. In addition, levels of
phospho-(S2448)-mTOR, total mTOR, and phospho-(T389)-
P70s6k were decreased by 100%, 80% (P=0.051 by two-tailed
Student’s t-test), and 95% (P=0.046 by two-tailed Student’s t-test),
Figure 2. BITC treatment results in cleavage of LC3 in breast cancer cells and MDA-MB-231 xenografts. (A) Immunoblotting for full-
length (LC3-I) and cleaved LC3 (LC3-II) using lysates from cells treated for specified time points with DMSO (control) or the indicated concentrations
of BITC. Densitometric quantitation for cleaved LC3 (LC-II) relative to corresponding DMSO-treated control is shown on top of the bands. Similar
results were obtained in two experiments using independently prepared lysates. (B) Immunoblotting for LC3-I and LC3-II using supernatants from
MDA-MB-231 xenografts harvested from control and 2.5 or 7.5 mmol BITC-treated mice. Tumor tissues from 4 different mice of each group were used
for immunoblotting. (C) Densitometric quantitation for cleaved LC3-II (arbitrary units). Results shown are mean 6 SD (n=4). *Significantly different
(P,0.05) by one-way ANOVA with Dunnett’s adjustment.
doi:10.1371/journal.pone.0032597.g002
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Figure 3. BITC-mediated growth inhibition is attenuated by autophagy inhibitors. (A) Immunohistochemical analysis for p62 expression in
MDA-MB-231 xenograft from a representative mouse of the control group and a mouse of the 7.5 mmol BITC treatment group. Enlarged images for
identified area are shown below. Quantitation of p62 expression is shown in the right hand panel. Six and four tumor sections, respectively, from
mice of control and 7.5 mmol BITC treatment groups were analyzed for p62 expression. Difference in p62 expression between control and 7.5 mmol
BITC groups was statistically significant (P= 0.043) by two-tailed Student’s t-test. Scale bar- 40 mm; 2006magnification. (B) Viability of MDA-MB-231,
MCF-7, MDA-MB-468 cells following 6 h treatment with 2.5 mM BITC in the absence or presence of 5 mM 3-MA or 3 nM Baf (2 h pre-treatment).
Results shown are mean 6 SD (n=3). Significantly different (P,0.05) compared with aDMSO-treated control and bBITC alone treatment group by
BITC Causes FoxO1-Mediated Autophagy
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respectively, in MDA-MB-231 xenografts from 7.5 mmol BITC-
treated mice compared with those from control mice (Fig. 4B).
These results demonstrated inhibition of mTOR by BITC in vitro
and in vivo.
We next conducted experiments involving transient overexpres-
sion of Rheb to determine the functional significance of mTOR
suppression in autophagic response to BITC. The Rheb activates
mTOR by antagonizing its endogenous inhibitor FKBP38 [24].
one-way ANOVA followed by Tukey’s multiple comparison test (for MDA-MB-231 and MCF-7 cells) or Bonferroni’s multiple comparison test (for MDA-
MB-468 cells). (C) Immunoblotting for Mn-SOD and LC3 using lysates from MDA-MB-231 cells stably transfected with the empty pcDNA3.1 vector or
the same vector encoding for Mn-SOD and treated for 6 h with DMSO or BITC (2.5 and 5 mM). Numbers above the bands represent densitometric
quantitation relative to empty vector-transfected cells treated with DMSO (lane 1). (D) Viability of empty vector-transfected control and Mn-SOD
overexpressing MDA-MB-231 cells following 6 h treatment with DMSO or 5 mM BITC. Results shown are mean 6 SD (n=3). *Significantly different
(P,0.05) between the indicated groups by one-way ANOVA followed by Bonferroni’s multiple comparison test. Each experiment was repeated and
representative data from one such experiment are shown.
doi:10.1371/journal.pone.0032597.g003
Figure 4. BITC treatment suppresses phosphorylation of mTOR and its targets in MDA-MB-231 and MCF-7 cells. (A) Immunoblotting
for phospho-(S2448)-mTOR, phospho-(S65)-4E-BP1, and phospho-(T389)-P70s6k using lysates from MDA-MB-231 and MCF-7 cells treated with DMSO
or BITC (2.5 or 5 mM BITC) for 6 or 12 h. Numbers on top of the bands represent change in protein level relative to corresponding DMSO-treated
control. Immunoblotting for each protein was performed at least twice using independently prepared lysates and the results were comparable. (B)
Immunoblotting for phospho-(S2448)-mTOR, total mTOR, and phospho-(T389)-P70s6k using supernatant from MDA-MB-231 xenografts harvested
from control mice (n=5) and 7.5 mmol BITC-treated mice (n= 4). Densitometric quantitation (mean arbitrary units 6 SD) for control and BITC-treated
groups is shown on top of the bands. Difference in expression of mTOR and phospho-P70s6k between control and BITC groups was statistically
significant by two-tailed Student’s t-test.
doi:10.1371/journal.pone.0032597.g004
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Ectopic expression of Rheb in MDA-MB-231 cells resulted in
activation of mTOR as evidenced by about 4.9-fold increase in
T389 phosphorylation of P70s6k (Fig. 5A). However, Rheb-
mediated activation of mTOR did not impart a meaningful
protection against BITC-induced cleavage of LC3 (Fig. 5A), LC3
puncta (Fig. 5B,C) or cell growth inhibition (Fig. 5D). These
observations were not unique to the MDA-MB-231 cell line
because Rheb-mediated activation of mTOR failed to confer any
protection against BITC-induced autophagy or growth inhibition
in the MCF-7 cell line (results not shown). These results indicated
that inhibition of mTOR was not a contributing mechanism in
execution of BITC-induced autophagy.
BITC Treatment Resulted in Increased Acetylation of
FoxO1
FoxO1 was recently identified as a critical regulator of
autophagy induction by H2O2 and serum starvation [25]. This
study also showed that autophagy was associated with acetylation
of FoxO1 leading to its increased interaction with Atg7 [25]. We
proceeded to test possible involvement of FoxO1 in autophagy
induction in our model. The level of total and acetylated FoxO1
was increased modestly in BITC-treated MDA-MB-231 and
MCF-7 cells (Fig. 6A). In addition, the BITC treatment resulted in
increased interaction between acetylated FoxO1 and Atg7 as
revealed by an experiment involving immunoprecipitation of
acetylated FoxO1 followed by immunoblotting with the use of
anti-Atg7 antibody (Fig. 6B). The BITC-mediated increase in total
FoxO1 protein level was evident in MDA-MB-231 xenografts in
Western blotting (Fig. 6C) as well as immunohistochemical
experiments (Fig. 6D). These results indicated induction and
increased acetylation of FoxO1 in breast cancer cells upon
treatment with BITC.
Knockdown of FoxO1 Protein Conferred Protection
Against BITC-Induced Autophagy
Level of FoxO1 protein was decreased by about 70% in MDA-
MB-231 cells transiently transfected with the FoxO1-targeted
siRNA in comparison with nonspecific siRNA-transfected cells
Figure 5. Role of mTOR suppression in BITC-induced autophagy. (A) Immunoblotting for HA-tag, phospho-(T389)-P70s6k, and LC3 using
lysates from MDA-MB-231 cells transiently transfected with the empty vector or vector encoding for HA-Rheb and treated with DMSO (control) or
2.5 mM BITC for 6 h. Densitometric quantitation relative to empty vector-transfected cells treated with DMSO is shown on top of the bands. (B)
Microscopic visualization of LC3 immunostaining in empty vector transfected control cells and HA-Rheb transfected MDA-MB-231 cells following 6 h
treatment with DMSO or 2.5 mM BITC (6100 objective magnification). (C) Percentage of cells with punctate LC3 in MDA-MB-231 cells transiently
transfected with the empty vector or vector encoding for HA-Rheb and treated with DMSO (control) or 2.5 mM BITC for 6 h. (D) Viability in MDA-MB-
231 cells transiently transfected with the empty vector or vector encoding for HA-Rheb and treated with DMSO (control) or 2.5 mM BITC for 6 h.
Results shown are mean 6 SD (n=3). *Significantly different (P,0.05) compared with corresponding DMSO-treated control by one-way ANOVA
followed by Bonferroni’s multiple comparison test. Each experiment was repeated twice and the results were comparable.
doi:10.1371/journal.pone.0032597.g005
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(Fig. 7A). Induction of FoxO1 protein was completely abolished by
RNA interference of FoxO1 (Fig. 7A). The BITC-mediated
cleavage of LC3 (Fig. 7A) and LC3 puncta (Fig. 7B,C) were clearly
evident in nonspecific siRNA-transfected MDA-MB-231 cells but
not in the cells transfected with FoxO1-specific siRNA. In
agreement with these results, RNA interference of FoxO1
conferred significant protection against BITC-mediated growth
inhibition in MDA-MB-231 cells (Fig. 7D). Level of FoxO1
protein was decreased by about 88% in MCF-7 cells transfected
with the FoxO1-targeted siRNA (Fig. 7E). RNA interference of
FoxO1 conferred significant protection against BITC-induced
cleavage of LC3 compared with nonspecific siRNA-transfected
MCF-7 cells (Fig. 7E). In addition, the MCF-7 cell line with
knockdown of FoxO1 protein was significantly more resistant to
BITC-mediated growth inhibition compared with corresponding
nonspecific siRNA-transfected cells (Fig. 7F). Together these
results pointed towards critical involvement of FoxO1 in
regulation of BITC-induced autophagy in both MDA-MB-231
and MCF-7 cells.
Discussion
The present study shows that BITC treatment causes autophagy
in breast cancer cells that is not influenced by the estrogen
Figure 6. BITC treatment causes acetylation of FoxO1 in MDA-MB-231 and MCF-7 cells. (A) Immunoblotting for FoxO1 and acetylated
FoxO1 (abbreviated as Ac.FoxO1) using lysates from MDA-MB-231 and MCF-7 cells treated with DMSO (control) or 2.5 and 5 mM BITC for the indicated
time periods. Densitometric quantitation relative to corresponding DMSO-treated control is shown on top of the bands. Similar results were obtained
in two experiments using independently prepared lysates. (B) Immunoblotting for Ac.FoxO1 and Atg7 using immunoprecipitates (using anti-
Ac.FoxO1 antibody) from the MDA-MB-231 and MCF-7 cells treated for 6 h with DMSO (control) or BITC (2.5 or 5 mM). (C) Immunoblotting for FoxO1
using supernatant from MDA-MB-231 xenografts harvested from control mice (n=5) and 7.5 mmol BITC-treated mice (n= 4). Densitometric
quantitation (mean arbitrary units 6 SD) for control and BITC treatment groups is shown on top of the bands. (D) Immunohistochemical analysis for
FoxO1 expression in MDA-MB-231 xenograft from a representative mouse of the control group and a mouse of the 7.5 mmol BITC group. Seven and
six tumor sections, respectively, from the mice of control and 7.5 mmol BITC treatment groups were analyzed for immunohistochemical analysis of
FoxO1. Scale bar- 100 mm (2006magnification).
doi:10.1371/journal.pone.0032597.g006
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receptor expression. Recent studies point towards an important
role of cytoplasmic p53 in regulation of autophagy [26]. The p53
status has no obvious impact on BITC-induced autophagy because
this response is observed in both MCF-7 (wild-type p53) and
MDA-MB-231 cells (mutant p53). Autophagic response to BITC is
not restricted to cultured breast cancer cells as MDA-MB-231
xenografts from the BITC-treated mice exhibit features charac-
teristic of autophagy, including cleavage of LC3 and suppression
of p62 expression. Autophagy induction by some stimuli
contributes to drug resistance in cancer cells [18,27]. For example,
inhibition of autophagy by chloroquine augments activity of the
alkylating agent cyclophosphamide in a Myc-driven model of
lymphoma [27]. We have also shown previously that D,L-
sulforaphane, a synthetic racemic analogue of broccoli constituent
L-sulforaphane, causes autophagy that serves to prevent cytosolic
release of cytochrome c and apoptosis in PC-3 and LNCaP human
prostate cancer cells [28]. The present study reveals that
autophagy is not a cytoprotective mechanism against growth
inhibition by BITC in breast cancer cells.
Evidence continues to accumulate to suggest that autophagic
response to some anti-cancer agents is mediated by ROS,
including arsenic trioxide [29,30]. Arsenic trioxide causes
apoptotic and/or autophagic death in cancer cells, and the
cytotoxicity of this agent is dependent on ROS production [29].
ROS-dependent autophagy induction by 2-methoxyestradiol, an
investigational anti-cancer agent currently in clinical trials, has also
Figure 7. FoxO1 is essential for BITC-induced autophagy in MDA-MB-231 and MCF-7 cells. (A) Immunoblotting for FoxO1 and LC3 using
lysates from MDA-MB-231 cells transiently transfected with a nonspecific siRNA or the FoxO1-targeted siRNA and treated for 6 h with DMSO or 5 mM
BITC. Numbers on top of the bands represent change in protein level relative to DMSO-treated nonspecific siRNA-transfected cells. (B)
Immunofluorescence microscopy for LC3 in MDA-MB-231 cells transiently transfected with a nonspecific siRNA or the FoxO1-targeted siRNA and
treated for 6 h with DMSO or 5 mM BITC. (C) Quantitation of LC3 puncta and (D) cell viability in MDA-MB-231 cells transiently transfected with a
nonspecific siRNA or the FoxO1-targeted siRNA and treated for 6 h with DMSO or 5 mM BITC. (E) Immunoblotting for FoxO1 and LC3 using lysates
from MCF-7 cells transiently transfected with a nonspecific siRNA or the FoxO1-targeted siRNA and treated for 6 h with DMSO or 5 mM BITC. Numbers
on top of the immunoreactive bands represent change in protein level relative to DMSO-treated nonspecific siRNA-transfected cells. (F) Viability of
MCF-7 cells transiently transfected with a nonspecific siRNA or the FoxO1-targeted siRNA and treated for 6 h with DMSO or 5 mM BITC. Results in
panels C, D, and F are mean6 SD (n=3). Significantly different (*P,0.05) between the indicated groups by one-way ANOVA followed by Bonferroni’s
test. Each experiment was done twice with similar results, and representative data from one such experiment are shown.
doi:10.1371/journal.pone.0032597.g007
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been demonstrated [31]. Mechanism by which ROS regulate
autophagy is not fully understood, but up-regulation of Beclin 1,
Atg4 oxidation, and mitochondrial dysfunction are some possibil-
ities explaining this relationship [32,33]. We have shown
previously that BITC treatment inhibits complex III of the
mitochondrial respiratory chain leading to ROS production in
MDA-MB-231 and MCF-7 cells [14]. Furthermore, prooxidant as
well as proapoptotic effects of BITC in these cells are significantly
attenuated by ectopic expression of catalase and SOD [14]. The
present study reveals that autophagic response to BITC in breast
cancer cells is partially dependent on ROS production. Suppres-
sion of ROS production through stable overexpression of Mn-
SOD confers partial protection against BITC-induced autophagy.
However, additional work is needed to test whether ROS-
dependent autophagy by BITC involves upregulation of Beclin
1, Atg4 oxidation, or any other mechanism.
Initially we focused on mTOR, which negatively regulates
autophagy in yeast and mammals [34], to gain insight into the
mechanism of BITC-induced autophagy. Even though BITC
treatment inhibits mTOR activity as evidenced by a reduction
in phosphorylation of its downstream targets (P70s6k and 4E-
BP1), autophagic response to BITC is not attenuated by
activation of mTOR through overexpression of its positive
regulator Rheb in either MDA-MB-231 or MCF-7 cells. To our
surprise, Rheb-mediated activation of mTOR fails to confer
any protection against cell killing or apoptotic DNA fragmen-
tation by BITC (Singh SV, unpublished observations) in either
MDA-MB-231 or MCF-7 cells. These observations are
intriguing because of established role of mTOR in regulation
of cell cycle, apoptosis, protein translation, and ribosomal
biogenesis [34,35].
FoxO1, a member of the forkhead O family of transcription
factors, is considered a tumor suppressor because of its ability to
cause cell cycle arrest and DNA repair [36]. Using serum-starved
(24 h) or H2O2-treated (0.5 mM, 6 h) H1299 human lung cancer
and HCT-116 human colon cancer cells as experimental models,
FoxO1 was identified as a mediator of autophagy [25]. FoxO1-
mediated autophagy was shown to be independent of its
transcriptional activity but accompanied by acetylation leading
to increased binding with Atg7 [25]. We reasoned that autophagic
response to BITC might be mediated by FoxO1. Indeed, we
observed that BITC treatment causes modest induction as well as
increased acetylation of FoxO1 in both MDA-MB-231 and MCF-
7 cells. Moreover, the BITC-mediated acetylation of FoxO1
promotes its interaction with Atg7 in both cells as evidenced by
immunoprecipitation-immunoblotting assay. Because BITC-in-
duced autophagy as well as cell growth inhibition is significantly
attenuated by knockdown of FoxO1, we conclude that this protein
plays a critical role in autophagic cell death by BITC treatment in
human breast cancer cells.
In conclusion, the present study shows that BITC treatment
causes FoxO1-mediated autophagic cell death in breast cancer
cells, which is neither a cell-line specific phenomenon nor affected
by the estrogen receptor or p53 status.
Methods
Ethics Statement
We used archived tumor tissues from our previously
published xenograft study [10] to obtain in vivo evidence for
BITC-induced autophagy. Use of mice and their care for this
study [10] was approved by the University of Pittsburgh
Institutional Animal Care and Use Committee (IACUC;
protocol number 1004983-4).
Reagents
BITC (purity- about 98%) and Baf were purchased from LKT
Laboratories (St. Paul, MN). Cell culture reagents, fetal bovine
serum, and OligoFECTAMINE were purchased from Invitrogen-
Life Technologies (Carlsbad, CA). The 3-MA and acridine orange
were purchased from Sigma-Aldrich (St. Louis, MO). Fugene6
and a kit for quantification of histone-associated DNA fragment
release into the cytosol were purchased from Roche Diagnostics
(Indianapolis, IN). Antibodies were purchased from the following
sources- anti-LC3 antibody recognizing both full-length and
cleaved forms was from MBL International (Woburn, MA);
antibodies against p62 (for immunoblotting), phospho-(S2448)-
mTOR, phospho-(T389)-P70s6k, phospho-(S65)-4E-BP1, FoxO1
(immunoblotting and immunohistochemistry), Atg7, and LC3
isoform B (LC3B) were from Cell Signaling Technology (Danvers,
MA); anti-acetylated FoxO1 and anti-HA antibodies were from
Santa Cruz Biotechnology (Santa Cruz, CA); anti-actin antibody
was purchased from Sigma-Aldrich; and anti-mTOR and anti-
Mn-SOD antibodies were from EMD Chemicals-Calbiochem
(Gibbstown, NJ). An antibody against mTOR used for immuno-
blotting using MDA-MB-231 xenograft supernatants was from
Cell Signaling Technology.
Cell Lines and Cell Viability Assay
The MDA-MB-231, MCF-7, MDA-MB-468, BT-474, and
MCF-10A cell lines were purchased from the American Type
Culture Collection (Manassas, VA) and maintained by following
the supplier’s recommendations. The BRI-JM04 cells, derived
from spontaneously developing mammary tumor of a MMTV-neu
mouse were generously provided by Dr. Anne Lenferink
(Biotechnology Research Institute, Montreal, Canada). Each cell
line was maintained at 37uC in an atmosphere of 95% air and 5%
CO2. Stock solution of BITC was prepared in DMSO and an
equal volume of DMSO (final concentration 0.1%) was added to
the controls. Effect of BITC on cell viability was determined by
trypan blue dye exclusion assay [37].
Transmission Electron Microscopy
The MDA-MB-231 cells (26105) were seeded in six-well plates
and allowed to attach by overnight incubation. The cells were then
treated with either DMSO (control) or 2.5 mM BITC for 6 or 12 h
at 37uC. Cells were fixed in ice-cold 2.5% electron microscopy
grade glutaraldehyde in phosphate-buffered saline (PBS) overnight
at 4uC. Fixed samples were washed three times in PBS, and then
post-fixed in 1% osmium tetroxide containing 0.1% potassium
ferricyanide for 1 h. Following three PBS washes, samples were
dehydrated through a graded series of 30% to100% ethanol.
Propylene oxide (100%) was then infiltrated in a 1:1 mixture of
propylene oxide and Polybed 812 epoxy resin (Epon) (Poly-
sciences, Warrington, PA) for 1 h. After several changes of 100%
resin over 24 h, samples were embedded in molds, cured at 37uC
overnight, followed by additional hardening at 65uC for 2 days.
Ultrathin (60 nm) sections were collected, and stained with 2%
uranyl acetate in 50% methanol for 10 min followed by staining
with 1% lead citrate for 7 min. Sections were imaged using JEOL
JEM 1011 transmission electron microscope (Peabody, MA).
Detection of Acidic Vesicular Organelles (AVOs)
The MDA-MB-231, MCF-7, MDA-MB-468, BT-474, BRI-
JM04, and MCF-10A cells (16105) were seeded on coverslips in
12-well plates and allowed to attach by overnight incubation.
Following treatment with DMSO (control) or BITC (5 mM) for 6
or 9 h, the cells were stained with 1 mg/mL acridine orange in
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PBS for 15 min, washed with PBS, and examined under a Leica
fluorescence microscope (Leica Microsystems, Bannockburn, IL)
at 1006 objective magnification.
Immunofluorescence Microscopy
The MDA-MB-231, MCF-7, MDA-MB-468, BT-474, BRI-
JM04, and MCF-10A cells (16105) were grown on coverslips in 12
well-plates and allowed to attach. The cells were then exposed to
the desired concentration of BITC or DMSO (control) for 6 or 9 h
at 37uC. The cells were washed with PBS and fixed in 2%
paraformaldehyde overnight at 4uC. The cells were permeabilized
with 0.1% Triton X-100 for 15 min at room temperature, washed
with PBS, and blocked with PBS containing 0.5% bovine serum
albumin and 0.15% glycine for 1 h at room temperature.
Following incubation with anti-LC3 antibody, cells were treated
with 2 mg/mL of Alexa Fluor 488 conjugated secondary antibody
for 1 h at room temperature. Ppunctate pattern of LC3 was
visualized under a microscope at 1006 objective magnification.
Cells with punctate LC3 were counted for each treatment group.
Western Blotting
Lysates from BITC-treated and DMSO-treated cells and
supernatants from MDA-MB-231 tumor xenografts were prepared
as described by us previously [38,39]. Lysate proteins were
resolved by 6–12.5% sodium dodecyl sulfate polyacrylamide gel
electrophoresis and transferred onto polyvinylidene fluoride
membrane. Immunoblotting was performed as described by us
previously [38,39]. Change in protein expression was determined
by densitometric scanning using UN-SCAN-IT software version
5.1 (Silk Scientific Corporation, Orem, Utah).
Immunohistochemical Analysis for p62 and FoxO1 in
MDA-MB-231 Xenografts
Immunohistochemistry was performed as previously described
for other proteins [39]. Briefly, MDA-MB-231 tumor sections (4–
5 mm) were quenched with 3% hydrogen peroxide and blocked
with normal serum. The sections were then probed with the
desired primary antibody (anti-p62 or anti-FoxO1), washed with
Tris-buffered saline, and incubated with an appropriate secondary
antibody. The characteristic brown color was developed by
incubation with 3,39-diaminobenzidine. The sections were coun-
terstained with Mayer’s Hematoxylin (Sigma-Aldrich) and exam-
ined under a Leica microscope. The images were captured and
analyzed with Image ProPlus 5.0 software (Media Cybernetics,
Bethesda, MD) as previously described [39]. At least four non-
overlapping images were captured and analyzed with the Red-
Green-Blue color histogram tool from Image ProPlus 5.0 software.
Stable Overexpression of Mn-Superoxide Dismutase (Mn-
SOD)
MDA-MB-231 cells were stably transfected with empty
pcDNA3.1 vector or pcDNA3.1 vector encoding for Mn-SOD
(8 mg plasmid DNA) using Fugene6. The cells were selected by
culture in medium supplemented with 800 mg/mL G-418 over 2
months. Mn-SOD overexpression in stably transfected cells was
confirmed by immunoblotting. The cells were processed for LC3
immunoblotting, trypan blue dye exclusion assay, and analysis of
histone-associated DNA fragment release into the cytosol, which is
a well-accepted technique for quantitation of apoptotic cell death.
Histone-associated DNA fragment release into the cytosol was
determined using Cell Death ELISA Detection kit from Roche
Diagnostics-USA (Indianapolis, IN) according to the manufactur-
er’s instructions.
Overexpression of Rheb
The MDA-MB-231 and MCF-7 cells (26105) were plated in 6-
well plates, allowed to attach overnight, and transiently transfected
with 2–4 mg of pcDNA3.1 vector encoding for HA-Rheb or empty
vector using Fugene6 transfection regent. After 24 h, the cells were
treated with DMSO (control) or 2.5 mM BITC for 6 h. The cells
were then processed for immunoblotting (HA tag, phospho-P70s6k
or LC3), immunofluorescence microscopy for LC3, and trypan
blue dye exclusion assay.
Immunoprecipitation-Immunoblotting Assay for FoxO1-
Atg7 Interaction
Aliquots containing 200 mg of total lysate protein from cells
treated for 6 h with DMSO (control) or BITC (2.5 or 5 mM) were
incubated overnight at 4uC with 4 mg of anti-acetylated FoxO1
antibody. Protein G-agarose beads (50 mL; Santa Cruz Biotech-
nology) were then added to each sample and the incubation was
continued for an additional 2 h at 4uC. Immunoprecipitates were
washed five times with lysis buffer and subjected to sodium-
dodecyl sulfate polyacrylamide gel electrophoresis followed by
immunoblotting using anti-acetylated FoxO1 or anti-Atg7 anti-
body.
RNA Interference of FoxO1
Cells (16105 cells in 6-well plates) were transfected at 30–50%
confluency with either 200 nM FoxO1-targeted siRNA (Cell
Signaling Technology) or a control non-specific siRNA (Qiagen,
Valencia, CA). After 24 h, the cells were exposed to desired
concentration of BITC or DMSO and the incubation was
continued for an additional 6 h. Cells were then collected and
processed for immunoblotting of FoxO1 and LC3, immunofluo-
rescence microscopy for LC3 localization, and trypan blue dye
exclusion assay.
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